XERS
#2173
Xeris Biopharma Holdings, Inc. - Common Stock
8.6 0 USD
-0.01%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-0.92%
Monthly Change
+4.50%
6 month change
+21.30%
Year Change
+8.72%
Previous Close
8.6 8
Open
8.6 0
Low
8.6 0
High
8.6 0
Volume
158
Financials
- Market Capitalization 1.57 B
- Employee 435
- Founded 2005
- CEO N/A
- Website www.xerispharma.com
- Headquarter Illinois, United States
- FIGI BBG012V1MG52
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
—
Price to sales ratio
4.65
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2150 |  FBRX Forte Biosciences, Inc. - Common Stock | 76.99 USD | 0.00% | +0.08% | +0.50% | +162.32% | 1.63 B USD | ||
| 2160 |  ABSI Absci Corporation - Common Stock | 9.42 USD | +2.17% | -1.46% | +33.05% | +281.38% | 1.62 B USD | ||
| 2175 |  TYRA Tyra Biosciences, Inc. - Common Stock | 26.13 USD | -0.34% | +0.69% | -16.57% | +82.22% | 1.56 B USD | ||
| 2178 |  LBRX LB Pharmaceuticals Inc - Common Stock | 47.89 USD | -0.58% | +0.38% | +36.28% | +152.05% | 1.54 B USD |
Frequently asked questions about Xeris Biopharma Holdings, Inc. Common Stock
What is the Xeris Biopharma Holdings, Inc. Common Stock stock price today?
The current price of Xeris Biopharma Holdings, Inc. Common Stock (XERS) is 8.6. Over the past 24 hours, the stock has changed by -0.92%. Follow the XERS chart for real-time price dynamics.
What is the stock ticker of Xeris Biopharma Holdings, Inc. Common Stock?
Xeris Biopharma Holdings, Inc. Common Stock trades under the ticker XERS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Xeris Biopharma Holdings, Inc. Common Stock stock going up?
XERS has changed by -0.12% over the last week, +4.50% over the last month, and +8.72% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Xeris Biopharma Holdings, Inc. Common Stock?
Xeris Biopharma Holdings, Inc. Common Stock currently has a market capitalization of 1.57 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Xeris Biopharma Holdings, Inc. Common Stock earnings last quarter?
Last quarter, Xeris Biopharma Holdings, Inc. Common Stock reported earnings of -0.18 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Xeris Biopharma Holdings, Inc. Common Stock revenue for the last quarter?
Xeris Biopharma Holdings, Inc. Common Stock reported quarterly revenue of 92.1 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Xeris Biopharma Holdings, Inc. Common Stock net income for the last quarter?
Xeris Biopharma Holdings, Inc. Common Stock reported net income of -31.1 M for the last quarter. The previous quarter showed 11.08 M, which means net income changed by -380.67%.
How many employees does Xeris Biopharma Holdings, Inc. Common Stock have?
As of the latest available data, Xeris Biopharma Holdings, Inc. Common Stock has 435 employees. Workforce size can provide additional context about the company's scale and operations.
What is Xeris Biopharma Holdings, Inc. Common Stock EBITDA?
Xeris Biopharma Holdings, Inc. Common Stock EBITDA is -68.05 M, and its EBITDA margin is -73.89%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Xeris Biopharma Holdings, Inc. Common Stock stock?
You can buy Xeris Biopharma Holdings, Inc. Common Stock (XERS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Xeris Biopharma Holdings, Inc. Common Stock stock?
Investing in Xeris Biopharma Holdings, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the XERS chart and related analysis on metatrader.com as part of your research.